搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
CMAJ
2 天
Glucagon-like peptide-1 receptor agonists for treating chronic kidney disease in patients ...
In a randomized controlled trial of people with type 2 diabetes, albuminuria, and estimated glomerular filtration rate (eGFR) ...
5 小时
Supplements claiming to work like Ozempic and Wegovy are now being sold – here’s what ...
Berberine, green tea extract and taurine are just some of the ingredients advertised as being able to ‘boost’ GLP-1 levels.
9 小时
How to preserve muscle mass on weight-loss drugs like Wegovy
There is some debate as to whether GLP-1 agonist drugs like Wegovy can lead to unhealthy muscle mass loss in addition to ...
22 小时
on MSN
Wegovy costs $1,349 in the US vs. $92 in the UK. Why are weight loss drugs so pricey?
About 42% of U.S. adults are obese, the CDC says. GLP-1 medications have changed the picture for people hoping to reduce ...
Yahoo News
12 小时
Thanksgiving on Ozempic: Here’s how to enjoy the meal with a smaller appetite
GLP-1 (glucagon-like peptide-1) medications reduce appetite by sending signals of fullness to the brain and slowing down ...
6 天
北大校友发现新型神经元,能通过靶向激活快速抑制食欲,或促进司 ...
近日,减重版司美格鲁肽正式在中国上市的消息引起众多关注。提起这种药,就必须提到一种主要由肠道 L 细胞所产生的激素——胰高糖素样肽-1(glucagon-like peptide-1,GLP-1)。该药物正是基于 GLP-1 研发而来。
Medscape
13 小时
GLP-1 Labels Don’t Reflect Trial Exclusions
Clinicians are advised to screen patients for conditions that would have rendered them ineligible to participate in the ...
Medscape
10 小时
Semaglutide Rocketing Past Statins as Millions Eligible
A new study suggests that 40% of American adults have conditions that could benefit from semaglutide treatment.
News Medical on MSN
7 天
Impact of glucagon-like peptide-1 receptor agonists on alcohol consumption
The impact of GLP-1 RAs on alcohol use is explored, showing potential benefits in reducing intake and cravings, but with ...
21 小时
What's Next for Amgen Obesity Drug After Investors Disappointed by Results
Shares in Amgen fell on Tuesday after they announced the results of a trial for their weight loss drug MariTide.
3 小时
on MSN
Amgen Drug Delivers More Weight Loss Than Competitors
A new weight loss drug developed by Amgen may provide better results with fewer injections than current treatments such as ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈